Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Optimized anti-TL1A antibodies

Optimized anti-TL1A antibodies

US Patent 11440954 · Granted Sep 13, 2022

Estimated economic value: $41,339,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-ROR1 antibodies and compositions2025
Anti-ROR1 antibodies and compositions2025
Histidyl-tRNA synthetase-Fc conjugates and therapeutics using the same2025
ROR1 antibody immunoconjugates2025
Methods of enriching or amplifying nucleic acids in a sample from a patient with2025
Methods and systems for selection and treatment of patients with inflammatory di2025
Methods and systems for selection and treatment of patients with inflammatory di2025
Methods and systems for selection and treatment of patients with inflammatory di2025
Methods and systems for selection and treatment of patients with inflammatory di2025
Signature of TL1A (TNFSF15) signaling pathway2025
Methods of treating refractory inflammatory disease using transcriptomic and gen2025
Methods of treating refractory inflammatory disease using transcriptomic and gen2025